Description
Cooper Cos. Could Win Big From the Myopia Boom—So Why Are Activists Pushing for Change?
The worsening global eyesight trend is turning into a significant business story for Cooper Companies. Rising digital-device use, changing lifestyles and growing rates of childhood myopia are expanding demand for vision correction and myopia-control products, placing CooperVision at the center of a long-duration healthcare trend. Its MiSight franchise is already showing meaningful growth, while premium daily, toric and multifocal contact lenses continue to expand across major markets. Yet the investment story extends well beyond eyesight. Activist investors Jana Partners and Browning West have pushed for changes after years of uneven stock performance, while Cooper is simultaneously evaluating the future of CooperSurgical. Management has received significant interest from potential buyers and has indicated that a large portion of any sale proceeds could be returned through share repurchases. The result is an unusual combination of consumer-health growth, activist pressure, portfolio restructuring and capital-allocation change that could redefine how investors view Cooper.
